SUTTON Paul, Allen,GIRGIS MICHAEL J.,LIANG JESSICA,PRASHAD MAHAVIR,VILLHAUER EDWIN BERNARD
申请号：
PL11770622
公开号：
PL2625172T3
申请日:
2011.10.05
申请国别(地区):
PL
年份:
2017
代理人:
摘要：
The present invention relates to novel crystalline forms of (4-{4-[5-(6-Trifluoromethylpyridin-3-ylamino)-pyridin-2-yl]-phenyl}-cyclohexyl)-acetic acid, sodium and their use in the treatment or prevention of a condition or a disorder associated with DGAT1 activity in animals, particularly humans. It also relates processes for making such novel crystalline forms.
